About Belco Pharma
Belco Pharma is a company based in Delhi (India) founded in 1975. Belco Pharma offers products and services including Pharmaceutical Formulations and R&D Services.
- Headquarter Delhi, India
- SectorsHealthcare
- Email••••••••
- Legal Name Belco Pharma Private Limited
- Date of Incorporation 10 Jan, 2020
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹12.2 Lakh
FY 2025 · -76% YoY
- Net Loss-₹35.5 Lakh
FY 2025 · -291% margin
- EBITDA-₹29.5 Lakh
FY 2025 · -241% margin
Associated legal entities of Belco Pharma
Belco Pharma operates through Belco Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Belco Pharma Private Limited CIN U74999DL2020PTC360147 | Active | 10 Jan 2020 | New Delhi, Delhi | ₹0.1 Cr | – | 2 | View details |
Products & Services of Belco Pharma
Belco Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and R&D Services.
Various dosage forms and categories of drugs are manufactured and developed by Belco Pharma
New products and pipelines are developed by Belco Pharma in the areas of global generics and branded generics
Board of directors of Belco Pharma Private Limited (Belco Pharma)
Belco Pharma Private Limited is the primary company behind Belco Pharma. The board of Belco Pharma Private Limited currently have 2 directors; the longest-serving is Kapil Singla, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kapil Singla DIN 08665941 | Director | 10 Jan 2020 | 6 yrs 8 mo | Belco Pharma Private Limited |
| Puneet Singla DIN 08665942 | Director | 10 Jan 2020 | 6 yrs 8 mo | Belco Pharma Private Limited |
Financials of Belco Pharma
Figures of Belco Pharma Private Limited, the primary company behind Belco Pharma, for FY 2025. Revenue was ₹12.2 Lakh (-76% year on year). Net loss was -₹35.5 Lakh (-291% margin). EBITDA was -₹29.5 Lakh (-241% margin).
- ₹12.2 LakhRevenue · FY 2025 · -76% YoY
- -₹35.5 LakhNet loss · -291% margin
- -₹29.5 LakhEBITDA · -241% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Belco Pharma Private Limited are on its company page.
Detailed financial statements for Belco Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Belco Pharma
Websites that share an audience with Belco Pharma (belcoindia.com).
Websites whose visitors overlap most with Belco Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cooperpharma.com | 100% | 17.9K | #1,398,892 | View details | |
| finecurepharma.com | 100% | 2.2K | #5,631,169 | View details | |
| versapharm.com | 100% | – | – | View details | |
| chemdiv.com | 100% | 20.9K | #1,521,986 | View details | |
| sentisspharma.com | 85% | 10.3K | #1,920,442 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Belco Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Belco Pharma
10 companies that operate in the same segment as Belco Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Belco Pharma
Belco Pharma was founded in 1975.
Belco Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Belco Pharma, Belco Pharma Private Limited, reported revenue of ₹12.2 Lakh for FY 2025, down 76% year on year.
Belco Pharma is recognized as a WHO GMP certified entity that has been manufacturing pharmaceutical formulations since 1975. Over 300 products across various dosage forms and drug categories are produced by the company, which is noted as a leader in generics and branded generics in India. Operations are extended to international markets in about 25 countries, where strategic tie-ups with multinational and national companies are maintained for manufacturing and distribution purposes. RD efforts are focused on global generics and product pipelines to support these activities.
Belco Pharma offers Pharmaceutical Formulations and R&D Services.
Belco Pharma operates through Belco Pharma Private Limited.
The legal entities of Belco Pharma currently have 2 directors, including Kapil Singla, Puneet Singla.